24. 論文①:軽症患者対象のRCT
López-Medina E, López P, Hurtado IC, et al.
Effect of Ivermectin on Time to Resolution of
Symptoms Among Adults With Mild COVID-
19: A Randomized Clinical Trial.
JAMA. 2021 Apr 13;325(14):1426-1435.
PMID: 33662102; PMCID: PMC7934083.
43. 論文③ PubMed Clinical Queriesから
Popp M, Stegemann M, Metzendorf MI, et al.
Ivermectin for preventing and treating
COVID-19.
Cochrane Database Syst Rev. 2021 Jul
28;7:CD015017
PMID: 34318930.
44. 論文④ PubMed Clinical Queriesから
Deng J, Zhou F, Ali S, et al.
Efficacy and safety of ivermectin for the
treatment of COVID-19: A systematic review
and meta-analysis.
QJM. 2021 Sep 27:hcab247.
PMID: 34570241.
45. 論文⑤: PubMed Clinical Queriesから
Bryant A, Lawrie TA, Dowswell T, et al.
Ivermectin for Prevention and Treatment of
COVID-19 Infection: A Systematic Review,
Meta-analysis, and Trial Sequential Analysis
to Inform Clinical Guidelines.
Am J Ther. 2021 Jun 21;28(4):e434-e460.
PMID: 34145166.
73. 吸入ステロイド
Yu LM, Bafadhel M, Dorward J, et al;
PRINCIPLE Trial Collaborative Group.
Inhaled budesonide for COVID-19 in people
at high risk of complications in the community
in the UK (PRINCIPLE): a randomised,
controlled, open-label, adaptive platform trial.
Lancet. 2021 Aug 10:S0140-6736(21)01744-
X.
PMID: 34388395; PMCID: PMC8354567.
75. 抗アンドロゲン:Twitterから
McCoy J, Goren A, Cadegiani FA, et al.
Proxalutamide Reduces the Rate of
Hospitalization for COVID-19 Male
Outpatients: A Randomized Double-Blinded
Placebo-Controlled Trial.
Front Med (Lausanne). 2021 Jul
19;8:668698.
PMID: 34350193; PMCID: PMC8326462.